Xiaoping Wu Selected Research

Autoimmune Diseases (Autoimmune Disease)

1/2020	Neutrophil elastase triggers the development of autoimmune diabetes by exacerbating innate immune responses in pancreatic islets of non-obese diabetic mice.
11/2012	Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoping Wu Research Topics

Disease

35	Neoplasms (Cancer) 02/2022 - 10/2007
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
6	Hemorrhage 03/2022 - 03/2013
6	Infections 11/2021 - 01/2017
6	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 05/2013
6	Carcinogenesis 01/2021 - 10/2013
6	Neoplasm Metastasis (Metastasis) 03/2020 - 01/2016
5	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 03/2015
5	Lung Neoplasms (Lung Cancer) 01/2019 - 06/2011
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2013
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 04/2015
4	Fibrosis (Cirrhosis) 12/2018 - 04/2015
3	Glioma (Gliomas) 10/2022 - 10/2012
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2010
3	COVID-19 07/2021 - 01/2021
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2010
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 01/2020
3	Obesity 01/2021 - 01/2017
3	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 03/2015
3	Virus Diseases (Viral Diseases) 01/2020 - 03/2016
3	Thrombosis (Thrombus) 01/2016 - 01/2013
3	Tuberous Sclerosis (Bourneville's Disease) 04/2015 - 01/2008
2	Cognitive Dysfunction 12/2022 - 02/2022
2	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2014
2	Treatment-Resistant Depressive Disorder 01/2022 - 01/2022
2	Wounds and Injuries (Trauma) 12/2021 - 01/2008
2	Inflammation (Inflammations) 08/2021 - 01/2020
2	Intervertebral Disc Degeneration 01/2021 - 01/2020
2	Pain (Aches) 01/2021 - 01/2020
2	Liver Neoplasms (Liver Cancer) 05/2020 - 04/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 11/2012
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2013
2	Weight Loss (Weight Reduction) 06/2017 - 03/2013
2	Melanoma (Melanoma, Malignant) 10/2013 - 08/2012
2	Alexander Disease (Alexander's Disease) 04/2013 - 04/2010
2	Gliosis 06/2012 - 01/2008
2	Cholestasis 05/2012 - 06/2011
2	Hemangioma (Angioma) 10/2010 - 09/2010
1	Non-alcoholic Fatty Liver Disease 04/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022
1	Postoperative Cognitive Complications 02/2022

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2010
11	Peptides (Polypeptides)IBA 01/2020 - 05/2010
9	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2015 - 01/2010
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
7	Long Noncoding RNAIBA 06/2022 - 06/2017
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2016
4	EnzymesIBA 02/2021 - 11/2012
4	Fatty Acid-Binding ProteinsIBA 01/2021 - 01/2017
4	CollagenIBA 01/2021 - 01/2013
3	LipidsIBA 04/2022 - 10/2010
3	Cadherins (E-Cadherin)IBA 01/2022 - 03/2020
3	CytokinesIBA 01/2022 - 01/2013
3	CateninsIBA 01/2022 - 10/2017
3	MicroRNAs (MicroRNA)IBA 04/2020 - 01/2016
3	AntibodiesIBA 12/2019 - 10/2011
3	Fibroblast Growth Factor 8IBA 11/2018 - 05/2013
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2017 - 01/2011
3	trans-sodium crocetinate (crocetin)IBA 04/2015 - 01/2008
2	HDL CholesterolIBA 04/2022 - 02/2021
2	von Willebrand FactorIBA 03/2022 - 01/2018
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 02/2022 - 08/2012
2	Polysaccharides (Glycans)IBA 02/2022 - 02/2018
2	Biological ProductsIBA 01/2022 - 01/2020
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2022
2	fibroblast growth factor 21IBA 01/2021 - 01/2011
2	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2018
2	Therapeutic UsesIBA 01/2021 - 03/2020
2	Cytidine Diphosphate (CDP)IBA 01/2021 - 01/2020
2	Insulin (Novolin)FDA Link 01/2021 - 01/2020
2	HMGB1 Protein (HMG1)IBA 09/2020 - 08/2017
2	Chloroquine (Aralen)FDA LinkGeneric 05/2020 - 01/2016
2	Circular RNAIBA 01/2020 - 12/2018
2	VaccinesIBA 12/2019 - 06/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 06/2019 - 04/2015
2	Hematoxylin (Haematoxylon)IBA 06/2019 - 04/2015
2	ImmunosorbentsIBA 01/2019 - 11/2012
2	FibrinIBA 01/2018 - 01/2016
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017 - 01/2015
2	Phosphotransferases (Kinase)IBA 10/2013 - 05/2012
2	Glial Fibrillary Acidic ProteinIBA 04/2013 - 04/2010
2	Mitogen-Activated Protein KinasesIBA 10/2012 - 08/2012
2	acetyl- phenylalanyl- threonyl- leucyl- aspartyl- alanyl- aspartyl- phenylalanineIBA 01/2012 - 01/2010
2	ElementsIBA 10/2010 - 09/2010
2	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2008 - 04/2007
1	ManganeseIBA 12/2022
1	Antisense RNA (Anti-Sense RNA)IBA 06/2022
1	Uric Acid (Urate)IBA 04/2022
1	Neuroprotective AgentsIBA 02/2022
1	Isoflurane FDA LinkGeneric 02/2022
1	AntioxidantsIBA 02/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2022
1	SmokeIBA 01/2022

Therapy/Procedure

22	Therapeutics 01/2022 - 10/2007
2	Microelectrodes 10/2022 - 01/2020
2	Stents 01/2022 - 06/2014
2	Drug Therapy (Chemotherapy) 01/2021 - 08/2020
1	Heart-Assist Devices 03/2022